These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24273045)

  • 1. Targeted nasal vaccination provides antibody-independent protection against Staphylococcus aureus.
    Misstear K; McNeela EA; Murphy AG; Geoghegan JA; O'Keeffe KM; Fox J; Chan K; Heuking S; Collin N; Foster TJ; McLoughlin RM; Lavelle EC
    J Infect Dis; 2014 May; 209(9):1479-84. PubMed ID: 24273045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal vaccination with adjuvant-free S. aureus antigens effectively protects mice against experimental sepsis.
    Stegmiller NP; Barcelos EC; Leal JM; Covre LP; Donatele DM; de Matos Guedes HL; Cunegundes MC; Rodrigues RR; Gomes DC
    Vaccine; 2016 Jun; 34(30):3493-9. PubMed ID: 27091687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity.
    Choi SJ; Kim MH; Jeon J; Kim OY; Choi Y; Seo J; Hong SW; Lee WH; Jeon SG; Gho YS; Jee YK; Kim YK
    PLoS One; 2015; 10(9):e0136021. PubMed ID: 26333035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing antifungal immunity in pursuit of a Staphylococcus aureus vaccine strategy.
    Paterson MJ; Caldera JR; Nguyen C; Sharma P; Castro AM; Kolar SL; Tsai CM; Limon JJ; Becker CA; Martins GA; Liu GY; Underhill DM
    PLoS Pathog; 2020 Aug; 16(8):e1008733. PubMed ID: 32817694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17A plays an important role in protection induced by vaccination with fibronectin-binding domain of fibronectin-binding protein A against Staphylococcus aureus infection.
    Narita K; Asano K; Nakane A
    Med Microbiol Immunol; 2017 Jun; 206(3):225-234. PubMed ID: 28378247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a future for a Staphylococcus aureus vaccine?
    Proctor RA
    Vaccine; 2012 Apr; 30(19):2921-7. PubMed ID: 22115633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal vaccination with a double mutant of staphylococcal enterotoxin C provides protection against Staphylococcus aureus infection.
    Hu DL; Omoe K; Narita K; Cui JC; Shinagawa K; Nakane A
    Microbes Infect; 2006; 8(14-15):2841-8. PubMed ID: 17090392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of
    Soltan MA; Magdy D; Solyman SM; Hanora A
    OMICS; 2020 Apr; 24(4):195-204. PubMed ID: 32286190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
    mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity induced by Staphylococcus aureus surface protein A was protective against lethal challenge of Staphylococcus aureus in BALB/c mice.
    Yi SQ; Zhang XY; Yang YL; Yang Y; Liu SL; Fu L; Yu CM; Chen W
    Microbiol Immunol; 2012 Jun; 56(6):406-10. PubMed ID: 22420921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-10 (IL-10) Produced by Mutant Toxic Shock Syndrome Toxin 1 Vaccine-Induced Memory T Cells Downregulates IL-17 Production and Abrogates the Protective Effect against Staphylococcus aureus Infection.
    Narita K; Hu DL; Asano K; Nakane A
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31358568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of using a combination of staphylococcal superantigen-like proteins 3, 7 and 11 in a fusion vaccine for Staphylococcus aureus.
    Chan JYH; Clow F; Pearson V; Langley RJ; Fraser JD; Radcliff FJ
    Immunol Cell Biol; 2024; 102(5):365-380. PubMed ID: 38572664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.
    Brady RA; Mocca CP; Prabhakara R; Plaut RD; Shirtliff ME; Merkel TJ; Burns DL
    PLoS One; 2013; 8(4):e63040. PubMed ID: 23658662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNA-loaded PLGA nanoparticles improve humoral response againstS. aureus-mediated infections in a mouse model: subcutaneous vs. nasal administration strategy.
    Genta I; Colonna C; Conti B; Caliceti P; Salmaso S; Speziale P; Pietrocola G; Chiesa E; Modena T; Dorati R
    J Microencapsul; 2016 Dec; 33(8):750-762. PubMed ID: 27845595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to
    Proctor RA
    Microbiol Spectr; 2019 Jul; 7(4):. PubMed ID: 31298209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of vaccine against Staphylococcus aureus recovered from naturally occurring mastitis in she-camels.
    Aqib AI; Anjum AA; Ijaz M; Hussain R; Ahmed R; Farooqi SH; Aslam HB; Hussain K; Mehmood K; Zhang H
    Microb Pathog; 2018 Apr; 117():341-347. PubMed ID: 29510207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model.
    Schaffer AC; Solinga RM; Cocchiaro J; Portoles M; Kiser KB; Risley A; Randall SM; Valtulina V; Speziale P; Walsh E; Foster T; Lee JC
    Infect Immun; 2006 Apr; 74(4):2145-53. PubMed ID: 16552044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal immunity to staphylococcal toxic shock is controlled by the nasopharynx-associated lymphoid tissue.
    Fernandez S; Cisney ED; Hall SI; Ulrich RG
    Clin Vaccine Immunol; 2011 Apr; 18(4):667-75. PubMed ID: 21325486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of Staphylococcus aureus from
    Harro JM; Achermann Y; Freiberg JA; Allison DL; Brao KJ; Marinos DP; Sanjari S; Leid JG; Shirtliff ME
    Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31712267
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting the R domain of coagulase by active vaccination protects mice against lethal Staphylococcus aureus infection.
    Qian M; Zhao T; Li R; Yang Q; Yu R; Yin Y; Zai X; Li Y; Zhang J; Xu J; Chen W
    Microbes Infect; 2019; 21(3-4):163-169. PubMed ID: 30447395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.